Forbes January 13, 2026
Risa Labs, a Palo Alto–based health technology startup focused on oncology operations, has raised an $11.1 million Series A round to expand deployment of its AI operating system across cancer clinics, health systems, and specialty pharmacies in the United States.
The financing was co-led by Cencora Ventures and Optum Ventures, with participation from Oncology Ventures, Z21 Ventures, and John Simon through Ventureforgood. The round follows a $3.5 million seed raise announced last year, which supported early product development and initial customer deployments.
Founded in 2024 by Kshitij Jaggi and Kumar Shivang, Risa is building what it describes as an AI operating system for mission-critical healthcare workflows. Its first focus is oncology, an area where administrative complexity, payer rules, and staffing...







